Enanta Pharmaceuticals, Inc’s publication on the International Journal of Gastroenterology.
International Journal of Gastroenterology誌にて当社クライアントによる論文発表がありましたので紹介します。
Title: Characterization of EDP-305, a Highly Potent and Selective Farnesoid X Receptor Agonist, for the Treatment of Non-alcoholic Steatohepatitis
Read more…. http://www.sciencepublishinggroup.com/journal/paperinfo?journalid=282&doi=10.11648/j.ijg.20190301.12